For Laura Colón, director of Oncology at AstraZeneca Spainon this International Cancer Day, “We want to emphasize that in our company we work in many areas of research, both in DNA response and repair, as well as with conjugated antibodies, immuno-oncology, tumor markers or cell therapy, always with an ambitious commitment that “It is our main goal: to be able to talk, if not about a cure, then about chronicity of cancer, seeking the greatest possible benefit and less toxicity so that patients have a good quality of life.”.
Spain is a key country for the future of cancer research: we have some of the best researchers and clinicians in Oncology worldwide, who have made it possible to achieve very important developments in recent years; Thanks to this, a large number of patients benefit every year from research carried out by AstraZeneca in Oncology. “Thanks to the fruit of our work, and with the help of the best specialists, today we are able to offer patients different treatments for lung, breast, prostate cancer, gynecological, urological, gastrointestinal and hematological tumors, and in a “In the near future we hope to be able to offer new therapies in other pathologies, based on novel approaches, such as the development of small molecules and T cell receptors against solid tumors”Add Rick R Suarez.
There are many challenges ahead, such as guaranteeing equitable access to quality care, strengthening health systems to increase screening and access to biomarker tests and early diagnosis in cancer. In this sense, it is essential to continue working to guarantee universal access to oncological treatments that are increasingly aimed at promoting personalized Precision Medicine adjusted to the characteristics of each patient. It is necessary to continue advancing in the development of implementation plans and guarantee of access to these tests. “Our goal is that, in the coming years, the approach to the disease, precision medicine and access to innovative treatments have advanced so much that it will not be necessary to remember World Cancer Day as a commemoration, but as a reason for celebration.” ”concludes Martha Moreno.